Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2014
|
| In: |
Journal of clinical oncology
Year: 2014, Jahrgang: 32, Heft: 36, Pages: 4127-4133 |
| ISSN: | 1527-7755 |
| DOI: | 10.1200/JCO.2013.54.6861 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1200/JCO.2013.54.6861
|
| Verfasserangaben: | Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N. |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1504042328 | ||
| 003 | DE-627 | ||
| 005 | 20220812004246.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 150619s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1200/JCO.2013.54.6861 |2 doi | |
| 035 | |a (DE-627)1504042328 | ||
| 035 | |a (DE-576)434042323 | ||
| 035 | |a (DE-599)BSZ434042323 | ||
| 035 | |a (OCoLC)1340692110 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II) |b extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group |c Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N. |
| 264 | 1 | |c 2014 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 19.06.2015 | ||
| 700 | 1 | |a Pfreundschuh, Michael |d 1949-2018 |0 (DE-588)108615871 |0 (DE-627)394701879 |0 (DE-576)289617227 |4 oth | |
| 700 | 1 | |a Witzens-Harig, Mathias |0 (DE-588)1050736516 |0 (DE-627)784812322 |0 (DE-576)404988970 |4 oth | |
| 773 | 0 | 8 | |i In |t Journal of clinical oncology |d Alexandria, Va. : American Society of Clinical Oncology, 1983 |g 32(2014), 36, Seite 4127-4133 |h Online-Ressource |w (DE-627)313116962 |w (DE-600)2005181-5 |w (DE-576)090887018 |x 1527-7755 |7 nnas |a Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II) extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group |
| 773 | 1 | 8 | |g volume:32 |g year:2014 |g number:36 |g pages:4127-4133 |g extent:7 |a Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II) extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1200/JCO.2013.54.6861 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20150619 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 1050736516 |a Witzens-Harig, Mathias |m 1050736516:Witzens-Harig, Mathias |d 910000 |d 910100 |e 910000PW1050736516 |e 910100PW1050736516 |k 0/910000/ |k 1/910000/910100/ |p 12 | ||
| 999 | |a KXP-PPN1504042328 |e 2846743673 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"7 S."}],"relHost":[{"origin":[{"publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]","publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins","dateIssuedKey":"1983","dateIssuedDisp":"1983-"}],"id":{"zdb":["2005181-5"],"eki":["313116962"],"issn":["1527-7755"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Journal of clinical oncology","title":"Journal of clinical oncology","subtitle":"JCO : an American Society of Clinical Oncology journal"}],"pubHistory":["1.1983 -"],"part":{"year":"2014","pages":"4127-4133","issue":"36","text":"32(2014), 36, Seite 4127-4133","volume":"32","extent":"7"},"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}],"disp":"Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II) extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study GroupJournal of clinical oncology","note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"313116962","corporate":[{"display":"American Society of Clinical Oncology","roleDisplay":"Herausgebendes Organ","role":"isb"}],"language":["eng"]}],"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"2014"}],"id":{"doi":["10.1200/JCO.2013.54.6861"],"eki":["1504042328"]},"name":{"displayForm":["Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N."]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 19.06.2015"],"language":["eng"],"recId":"1504042328","title":[{"subtitle":"extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group","title":"Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II)","title_sort":"Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II)"}],"person":[{"role":"oth","display":"Pfreundschuh, Michael","given":"Michael","family":"Pfreundschuh"},{"display":"Witzens-Harig, Mathias","role":"oth","family":"Witzens-Harig","given":"Mathias"}]} | ||
| SRT | |a OPTIMIZATI2014 | ||